• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library

    Kyowa Kirin’s Biologics Crysvita Receives Suppl Approval in US

    FDA

    Kyowa Kirin`s Biologic Poteligeo Receives Suppl Approval in US

    FDA

    Kyowa Kirin`s Mogamulizumab Receives Supplemental Approval in the U.S.

    FDA

    Kyowa Kirin Holdings BV`s Poteligeo (mogamulizumab) Receives Approval in US

    EMA

    Kyowa Kirin`s Poteligeo(Mogamulizumab-Kpkc) Receives Supplemental Approval in US

    FDA

    Kyowa Kirin`s Crysvita (Burosumab) Receives Approval In Europe

    EMA

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.